Medication optimization intervention

Medication optimization intervention improves health-related quality of life in humans (β 4.02, 95% CI 0.11-7.93, p = 0.044).

“Non-long stayers of the intervention group reported significantly higher EQ-VAS than the control group (β 4.02 [0.11-7.93], p = 0.044).”

Human trialnon-long stayers (< 14 days)

Health-related quality of life among older adults following acute hospitalization: longitudinal analysis of a randomized controlled trial

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·Jun 17, 2024